Literature DB >> 6146548

Effect of caerulein administration on portal plasma somatostatin in dogs.

J Kasanuki, S Fujimoto, H Makino, A Kanatsuka, T Imaizumi, H Koseki, R Kaneko, Y Tokumasa, S Yoshida.   

Abstract

The effect of administration of synthetic caerulein on canine plasma somatostatin concentration in the portal vein was investigated using specific radioimmunoassay of acid-acetone extracted plasma. Gel chromatography revealed that the main component of the plasma somatostatin in the portal vein was identical with somatostatin-14. After administration of caerulein (5 ng/kg), the somatostatin level increased significantly while the gastrin level remained unchanged. These results suggested that caerulein affects D cell function but not gastrin secretion.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6146548     DOI: 10.1007/bf02779173

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  24 in total

1.  Radioimmunoassay for GH-release inhibiting hormone.

Authors:  A Arimura; H Sato; D H Coy; A V Schally
Journal:  Proc Soc Exp Biol Med       Date:  1975-03

2.  Immunoreactive somatostatin in rat hypophyseal portal blood: effects of anesthetics.

Authors:  K Chihara; A Arimura; A V Schally
Journal:  Endocrinology       Date:  1979-05       Impact factor: 4.736

3.  The characterization of somatostatin-like immunoreactivity in human serum.

Authors:  S Kronheim; M Berelowitz; B L Pimstone
Journal:  Diabetes       Date:  1978-05       Impact factor: 9.461

4.  The nature of big plasma somatostatin: implications for the measurement of somatostatin-like immunoreactivity in human plasma.

Authors:  J M Conlon; M Bridgeman; K G Alberti
Journal:  Anal Biochem       Date:  1982-09-15       Impact factor: 3.365

5.  Evidence for the hormonal status of somatostatin in man.

Authors:  E S Zyznar; A O Pietri; V Harris; R H Unger
Journal:  Diabetes       Date:  1981-10       Impact factor: 9.461

6.  Release of pancreatic and gastric somatostatin-like immunoreactivity in response to the octapeptide of cholecystokinin, secretin gastric inhibitory polypeptide, and gastrin-17 in dogs.

Authors:  D Rouiller; V Schusdziarra; V Harris; R H Unger
Journal:  Endocrinology       Date:  1980-08       Impact factor: 4.736

7.  Effects of gastrin on circulating levels of somatostatin, pancreatic polypeptide, and vasoactive intestinal peptide in dogs.

Authors:  S Guzman; J Lonovics; J A Chayvialle; K E Hejtmancik; P L Rayford; J C Thompson
Journal:  Endocrinology       Date:  1980-07       Impact factor: 4.736

8.  Isolation and structure of caerulein, an active decapeptide from the skin of Hyla caerulea.

Authors:  A Anastasi; V Erspamer; R Endean
Journal:  Experientia       Date:  1967-09-15

9.  Effect of caerulein upon insulin and glucagon secretion in dogs.

Authors:  A Ohneda; K Horigome; S Ishii; Y Kai; M Chiba
Journal:  Horm Metab Res       Date:  1978-01       Impact factor: 2.936

10.  The action of caerulein on pancreatic secretion of the dog and biliary secretion of the dog and the rat.

Authors:  G Bertaccini; G De Caro; R Endean; V Erspamer; M Impicciatore
Journal:  Br J Pharmacol       Date:  1969-09       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.